Selegiline Recalled
The US Food and Drug Administration (FDA) announced the recall of selegiline hydrochloride tablets, USP, 5mg (NDC 51862-146-06).
What prompted the Class III recalls? An “out of specification result for dissolution of stability samples” prompted the recall, according to the FDA’s Enforcement Report.
__________________________________________________________________________________________________________________________________________________________________________
RELATED CONTENT
Diabetes Med Recalled
1.9 Million Vials of Ephedrine Recalled
__________________________________________________________________________________________________________________________________________________________________________
The lots below are being recalled.
Lot |
Expiration |
14F030 |
June 2017 |
14F031 |
June 2017 |
14F032 |
June 2017 |
15G022 |
July 2018 |
The products were manufactured by Stason Pharmaceuticals, Inc. and distributed by Libertas Pharma, Inc.
Other medications used to treat Parkinson’s disease have been recalled. In one instance the discovery of the wrong pill prompted a recall. In another, the presence of an unknown impurity was discovered.
--Stephanie Vaccaro
Reference:
US Food and Drug Administration. FDA Enforcement Report – Week of September 14, 2016. www.fda.gov. Accessed September 14, 2016.